Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Adalimumab Solution for Injection

Approved

生物制品

Adalimumab Solution for Injection

百奥泰生物制药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Mar 23, 2021
Approval ID: 85XId9ft543
Company: 百奥泰生物制药股份有限公司
Type: 生物制品

Approval Details

Approval Id: 85XId9ft543
Approval Number: 国药准字S20217002
Generic Name: 阿达木单抗注射液
Generic Name En: Adalimumab Solution for Injection
Trade Name: 格乐立/QLETLI
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 20mg/0.4ml
Reg Date: 2021-03-23
Company Name: 百奥泰生物制药股份有限公司
Company Address: 广州市黄埔区永和经济开发区摇田河大街155号
Production Company Name: 百奥泰生物制药股份有限公司
Production Company Address: 广州市黄埔区永和经济开发区摇田河大街155号
Company Detail Path: /organization/bio-thera-solutions-ltd
Production Company Detail Path: /organization/bio-thera-solutions-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 23, 2021

Approval ID

85XId9ft543

Type

生物制品

Back to NMPA Approvals

格乐立/QLETLI - NMPA Drug Approval Details